A screening method for the optimal surface structure of embryonic stem cell culture using a cell culture plate comprising gradient nanopattern
KR20140091801A
Methods for Culturing Endothelial Progenitor Cells Derived from Human Umbilical Cord Bloods and Compositions for Preventing or Treating Ischemic Diseases Comprising Endothelial Progenitor Cells Derived from Human Umbilical Cord Bloods
KR20140047343A
Isolation of lung cancer cells and proliferation thereof using suspension culture method
KR20140021141A
Formulation for orodispersible film comprising aripirazole
WO2013015579A2
Medical composite organic material including collagen and hyaluronic acid derivatives
KR20130018518A
Medicinal composite biomaterial comprising collagen and hyaluronic acid derivative
CN103998048A
Method for manufacturing umbilical cord extract and usage of same
KR20130123659A
Fast dissolving oral dosage form of sildenafil improved the property of matter and shielding a bitter taste
KR20130118674A
Method for subculture of human single pluripotent stem cell and method for preparing transformed human pluripotent stem cell using the same
KR20130085308A
Method for producing human embryonic stem cell-derived perivascular progenitor cell and composition for cell therapy comprising the same
KR20130043520A
Method for the isolation and proliferation of primary lung cancer cells
KR20120100683A
Stable orodispersible film formulation
KR20120140176A
Reflection optical system for object recognition and moving robot using the same
KR20130007751A
Methods for preparing extract of umbilical cord and uses thereof
KR20120117386A
Adipose-derived stem cell, method for separating the same and method for storing the same
KR20120109010A
Pharmaceutical composition for preventing or treating gastrointestinal damage comprising kauran derivatives
KR20120098202A
Placenta extract and process for producing the same
KR20120096793A
Composition for preventing immune-respose comprising placenta derived stem cell
KR20120090485A
Process for preparing lymphocytes comprising activated natural killer cells for targeting cancer cells and pharmaceutical composition comprising the same
